Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
FCI Ophthalmics Introduces EzyPor PE Orbital Implant in USI OBN
FCI Ophthalmics announced the launch of EzyPor in the United States. EzyPor is a polyethylene orbital implant with a proprietary suturing platform that is suggested for enucleation, evisceration, and secondary implantation. Ezypor is developed with a smooth anterior suturing surface…
HOYA Surgical Optics Acquires Mid Labs and Fritz Ruck
HOYA Surgical Optics (“HSO”), the intraocular lens and related products division of HOYA Group, today announced that it has completed the acquisition of medical device companies Mid Labs and Fritz Ruck. Mid Labs is a California-based company focused on the…
Alcon Introduces Launch Of AcrySof IQ Vivity
Development of active glasses for mitigating presbyopia has become an active area of research, facilitated by the miniaturization of focus-tunable lenses as well as the increased processing power of modern computers. Alcon the global leader in eye care dedicated to…
Ophthalmic Market Projected to Reach $532.8M by 2026
The global ophthalmic sutures market size is expected to reach USD 532.8 million by 2026, expanding at a CAGR of 6.4% over the forecast period, according to a new report by Grand View research, Inc. Key factors driving the market…
Cataract Journey and Medical Staff’s Role in Patient Care
Cataract surgery is the most frequently performed operative procedure worldwide, typically concludes with the implantation of an artificial intraocular lens (IOL) to correct aphakia (absence of the crystalline lens). The surgery—which involves removing the eye’s clouded lens and replacing it…
YAG Laser Capsulotomy Procedure | OBN
Cataract surgery has revolutionized the way we restore vision, but what happens when clarity begins to fade post-surgery? This is where YAG laser capsulotomy steps in, offering a solution that restores vision and rejuvenates the eyes. In this article, we’ll…
FDA Approves Lupin’s Bromfenac Ophthalmic Solution
Lupin Limited, a global pharmaceutical company, has officially received approval from the US FDA for its Abbreviated New Drug Application for Bromfenac Ophthalmic Solution, 0.09%. This approval allows Lupin to introduce a generic counterpart to Bausch & Lomb Inc.’s Bromday…
Conjunctivitis: Causes, Symptoms, and How to Manage It
Conjunctivitis, commonly known as “pink eye,” is a prevalent eye condition that affects people of all ages. Characterized by redness, itching, and discomfort in the eyes, conjunctivitis can be caused by various factors, including viruses, bacteria, allergies, and irritants. Understanding…
What Is Conjunctival Injection and How to Treat It
Conjunctival injection, commonly known as red eyes, is a condition characterized by the appearance of bloodshot or pinkish eyes. It occurs when the blood vessels on the conjunctiva, the thin membrane covering the front surface of the eye, become dilated…
MHRA Issues Warning for Nidek’s EyeCee Preloaded IOLs
The Medicines and Healthcare products Regulatory Agency (MHRA) has recently issued a National Patient Safety Alert due to reports of increased intraocular pressure in patients recently implanted with EyeCee One preloaded and EyeCee One Crystal preloaded intraocular lenses (IOLs), which…